Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Mol Genet Metab ; 131(3): 349-357, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33153867

RESUMEN

Isolated complex I (CI) deficiency is the most common cause of oxidative phosphorylation (OXPHOS) dysfunction. Whole-exome sequencing identified biallelic mutations in NDUFA8 (c.[293G > T]; [293G > T], encoding for an accessory subunit of CI, in two siblings with a favorable clinical evolution. The individuals reported here are practically asymptomatic, with the exception of slight failure to thrive and some language difficulties at the age of 6 and 9 years, respectively. These observations are remarkable since the vast majority of patients with CI deficiency, including the only NDUFA8 patient reported so far, showed an extremely poor clinical outcome. Western blot studies demonstrated that NDUFA8 protein was strongly reduced in the patients' fibroblasts and muscle extracts. In addition, there was a marked and specific decrease in the steady-state levels of CI subunits. BN-PAGE demonstrated an isolated defect in the assembly and the activity of CI with impaired supercomplexes formation and abnormal accumulation of CI subassemblies. Confocal microscopy analysis in fibroblasts showed rounder mitochondria and diminished branching degree of the mitochondrial network. Functional complementation studies demonstrated disease-causality for the identified mutation as lentiviral transduction with wild-type NDUFA8 cDNA restored the steady-state levels of CI subunits and completely recovered the deficient enzymatic activity in immortalized mutant fibroblasts. In summary, we provide additional evidence of the involvement of NDUFA8 as a mitochondrial disease-causing gene associated with altered mitochondrial morphology, CI deficiency, impaired supercomplexes formation, and very mild progression of the disease.


Asunto(s)
Predisposición Genética a la Enfermedad , Enfermedades Mitocondriales/genética , NADH Deshidrogenasa/genética , Fosforilación Oxidativa , Niño , Femenino , Fibroblastos/metabolismo , Humanos , Masculino , Errores Innatos del Metabolismo/genética , Errores Innatos del Metabolismo/patología , Mitocondrias/genética , Mitocondrias/patología , Enfermedades Mitocondriales/patología , Hermanos , Secuenciación del Exoma
2.
Influenza Other Respir Viruses ; 17(1): e13035, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36225128

RESUMEN

BACKGROUND: Seasonal influenza annually causes significant morbidity and mortality, and unpredictable respiratory virus zoonoses, such as the current COVID-19 pandemic, can threaten the health and lives of millions more. Molecular iodine (I2 ) is a broad-spectrum, pathogen-nonspecific antiseptic agent that has demonstrated antimicrobial activity against a wide range of bacteria, virus, and fungi. METHODS: We investigated a commercially available antiseptic, a non-irritating formulation of iodine (5% povidone-iodine) with a film-forming agent that extends the duration of the iodine's antimicrobial activity, for its ability to prevent influenza virus transmission between infected and susceptible animals in the guinea pig model of influenza virus transmission. RESULTS: We observed that a once-daily topical application of this long-lasting antiseptic to the nares of either the infected virus-donor guinea pig or the susceptible virus-recipient guinea pig, or to the nares of both animals, prior to virus inoculation effectively reduced transmission of a highly transmissible influenza A virus, even when the donor and recipient guinea pigs shared the same cage. Daily treatment of the recipient guinea pig starting 1 day after initial exposure to an infected donor guinea pig in the same cage was similarly effective in preventing detectable influenza virus infection in the recipient animal. CONCLUSIONS: We conclude that a daily application of this antiseptic formulation is efficacious in reducing the transmission of influenza A virus in the guinea pig model, and further study in this and other preclinical models is warranted.


Asunto(s)
Antiinfecciosos Locales , Antiinfecciosos , COVID-19 , Virus de la Influenza A , Gripe Humana , Yodo , Infecciones por Orthomyxoviridae , Animales , Cobayas , Humanos , Pandemias , Modelos Animales de Enfermedad , Antisepsia , Antiinfecciosos Locales/uso terapéutico
3.
Mol Biol Cell ; 17(8): 3446-55, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16760432

RESUMEN

The mitogen-activated protein kinase kinase (MEK) kinase 1 (MEKK1) mediates activin B signals required for eyelid epithelium morphogenesis during mouse fetal development. The present study investigates the role of MEKK1 in epithelial wound healing, another activin-regulated biological process. In a skin wound model, injury markedly stimulates MEKK1 expression and activity, which are in turn required for the expression of genes involved in extracellular matrix (ECM) homeostasis. MEKK1 ablation or down-regulation by interfering RNA significantly delays skin wound closure and impairs activation of Jun NH2-terminal kinases, induction of plasminogen activator inhibitor (PAI)-1, and restoration of cell-cell junctions of the wounded epidermis. Conversely, expression of wild-type MEKK1 accelerates reepithelialization of full-thickness skin and corneal debridement wounds by mechanisms involving epithelial cell migration, a cell function that is partially abolished by neutralizing antibodies for PAI-1 and metalloproteinase III. Our data suggest that MEKK1 transmits wound signals, leading to the transcriptional activation of genes involved in ECM homeostasis, epithelial cell migration, and wound reepithelialization.


Asunto(s)
Epitelio/enzimología , Epitelio/fisiología , Quinasa 1 de Quinasa de Quinasa MAP/metabolismo , Cicatrización de Heridas/inmunología , Activinas/metabolismo , Animales , Animales Recién Nacidos , Movimiento Celular , Córnea/citología , Activación Enzimática , Células Epidérmicas , Epidermis/patología , Células Epiteliales/citología , Matriz Extracelular/metabolismo , Expresión Génica , Humanos , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Queratinocitos/citología , Ratones , Ratones Endogámicos C57BL , Piel/citología , Piel/patología
4.
Mol Cell Biol ; 25(1): 60-5, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15601830

RESUMEN

Activins and other members of the transforming growth factor beta family play a critical role in morphological changes of the epidermis that require epithelial cell movement. We investigated the molecular pathways in the transmission of activin signals that lead to actin reorganization and epithelial cell migration. We found that activins cause the activation of RhoA but not of Rac and CDC42, leading to MEKK1-dependent phosphorylation of JNK and transcription factor c-Jun. Through a RhoA-independent mechanism, the activins also induce p38 activity in keratinocytes from wild-type but not from MEKK1-deficient mice. Although neither pathway is dependent on Smad activation, the MEKK1-mediated JNK and p38 activities are both essential for activin-stimulated and transcription-dependent keratinocyte migration. Only JNK is involved in transcription-independent actin stress fiber formation, which needs also the activity of ROCK. Because ROCK is required for JNK activation by RhoA and its overexpression leads to MEKK1 activation, we propose a RhoA-ROCK-MEKK1-JNK pathway and a MEKK1-p38 pathway as Smad-independent mechanisms in the transmission of activin signals. Together, these pathways lead to the control of actin cytoskeleton reorganization and epithelial cell migration, contributing to the physiologic and pathological effects of activins on epithelial morphogenesis.


Asunto(s)
Actinas/metabolismo , Activinas/metabolismo , Queratinocitos/metabolismo , Quinasa 1 de Quinasa de Quinasa MAP/fisiología , Transducción de Señal , Animales , Western Blotting , Movimiento Celular , Citoesqueleto/metabolismo , Activación Enzimática , Células Epiteliales/citología , GTP Fosfohidrolasas/metabolismo , Proteínas Fluorescentes Verdes/metabolismo , Guanosina Trifosfato/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , MAP Quinasa Quinasa 4 , Quinasa 1 de Quinasa de Quinasa MAP/metabolismo , Ratones , Microscopía Fluorescente , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Modelos Biológicos , Mutación , Fosforilación , Retroviridae/genética , Factores de Tiempo , Cicatrización de Heridas , Proteína de Unión al GTP cdc42/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Proteínas de Unión al GTP rac/metabolismo , Proteína de Unión al GTP rhoA/metabolismo
5.
FEMS Microbiol Ecol ; 94(8)2018 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-29931290

RESUMEN

The growing prevalence of antibiotic resistance poses an increasingly serious threat to human health. Although an important driver of antibiotic resistance is the continuous exposure of bacteria to sublethal concentrations of antibiotics in natural environments, antibiotic pollutants are not currently tracked globally or systematically. This limits the international capacity to address the rise of antibiotic resistance at its source. To address this lack of data, the development of methods to measure antibiotic concentrations on-site is essential. These methods, ideally, must be sensitive to sublethal concentrations of antibiotics and require minimal technical expertise. Furthermore, factors such as cost, selectivity, biosafety and the ability to multiplex must be evaluated in the context of field use. Based on these criteria, we provide a critical review of current methods in antibiotic detection and evaluate their adaptability for use on-site. We categorize these methods into microbiological assays, physical and chemical assays, immunoassays, aptasensors and whole-cell biosensors. We recommend continued development of a dipstick or microfluidics approach with a bacterial promoter-based mechanism and colorimetric output. This technique would incorporate the advantageous aspects of existing methods, maximize shelf-life and ease-of-use, and require minimal resources to implement in the field.


Asunto(s)
Antibacterianos/análisis , Bacterias/efectos de los fármacos , Bacterias/genética , Farmacorresistencia Bacteriana/genética , Monitoreo del Ambiente/métodos , Contaminantes Ambientales/análisis , Técnicas Biosensibles/métodos , Humanos , Microfluídica/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA